Price
CHART BY
Frequently asked questions
What is Attovia Therapeutics, Inc.'s market capitalization?
The market capitalization of Attovia Therapeutics, Inc. is $1.01B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What are the analyst ratings and target price for Attovia Therapeutics, Inc.'s stock?
Currently, 5 analysts cover Attovia Therapeutics, Inc.'s stock, with a consensus target price of $42.20. Analyst ratings provide insights into the stock's expected performance.
What is the free float of Attovia Therapeutics, Inc.'s shares?
The free float of Attovia Therapeutics, Inc. is 28.41M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.01B
- Free Float
- 28.41M
Pricing
- 52W span
- $16.20$27.58
Analyst Ratings
The price target is $42.20 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- ATTO
Fundamentals & EOD data from FactSet